RPG Life Sciences Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 18,681 shares,. Its Average Traded Price (ATP) is ₹2818.48, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹2824.50.
RPG Life Sciences has an upper circuit limit of ₹3286.90 and a lower circuit limit of ₹2191.30. The total value traded stands at ₹5.27 CR, and the delivery percentage for the day is 31.04%.
The stock is currently traded with a market lot size of 1. RPG Life Sciences also offers a dividend yield of 0.88%.
RPG Life Sciences Share Price Chart
RPG Life Sciences Share Key Metrics
Volume
18681.00
Market Cap
4671.44 CR
LTQ@LTP
2@2824.50
ATP
2818.48
Var Margin
19.94 %
Circuit Range
2191.3-3286.9
Delivery %
31.04 %
Value
5.27 CR
ASM/GSM
No
Market Lot
1
RPG Life Sciences Resistance and Support
Pivot 2709.87
Resistance
First Resistance
2789.24
Second Resistance
2839.37
Third Resistance
2918.74
Support
First Support
2659.74
Second Support
2580.37
Third Support
2530.24
RPG Life Sciences Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
RPG Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-27 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-04-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-09 | 2026-07-09 | View More |
RPG Life Sciences News
RPG Life Sciences Ltd - 532983 - Update On Investment And Shareholder Agreement
RPG Life Sciences' wholly-owned subsidiary, RPG Active Pharma Limited (RPGAP), allotted securities to India Life Sciences Fund IV Domestic (ILSF) and Vistaject Fund (VJF). The transaction totals Rs.243.33 crore, giving the funds a 40% equity stake in RPGAP, which remains a subsidiary of RPG Life Sciences.
Sep 09 2026 22:50:06
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
RPG Life Sciences' subsidiary, RPG Active Pharma, acquired the API business of Raghava Life Sciences for up to Rs. 135 crore. This strategic move adds 300 KL installed capacity and a portfolio of 22 commercialized APIs, strengthening RPGAP's integrated API play.
Sep 02 2026 22:23:17
RPG Life Sciences Ltd - 532983 - Intimation Of Execution Of BTA By RPG Active Pharma Limited (WOS) With Raghava Life Sciences Private Limited
RPG Life Sciences' wholly-owned subsidiary, RPG Active Pharma Limited, will acquire the Active Pharmaceutical Ingredients (APIs) and intermediates business of Raghava Life Sciences Private Limited. This slump sale acquisition is valued up to Rs.135 crores and aligns with RPG Life Sciences' strategy to expand its API business, adding 29 API molecules and business with FY26 revenue of Rs.19 cr.
Sep 02 2026 22:18:09
RPG Life Sciences Ltd - 532983 - Outcome Of Board Meeting
RPG Life Sciences' wholly-owned subsidiary, RPG Active Pharma Ltd, will acquire the API and intermediates business of Raghava Life Sciences Private Limited for up to Rs. 135 crores via slump sale. This acquisition aims to expand RPG Life Sciences' API portfolio, adding manufacturing facilities, R&D, and 29 API molecules.
Sep 02 2026 22:11:31
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
RPG Life Sciences will host an Analyst/Institutional Investors Meet on September 2, 2026. The meeting, organized by Ashwamedh - Elara India Dialogue 2026, will be a group/one-on-one format in Mumbai.
Aug 25 2026 20:02:29
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
RPG Life Sciences will participate in the Antique Healthcare Investor Conference 2026 on August 25, 2026. This physical group meet in Mumbai is for analysts and institutional investors to discuss the company's performance and outlook.
Aug 20 2026 18:09:11
RPG Life Sciences Management
| Name | Position |
|---|---|
| Harsh Goenka | Chairman |
| Ashok Nair | Managing Director |
RPG Life Sciences Similar Stocks
FDC Ltd.
352.15
1.95 (0.56%)
Gujarat Themis Biosyn Ltd.
420.15
7.55 (1.83%)
IOL Chemicals And Pharmaceuticals Ltd.
197.49
2.92 (1.50%)
Artemis Medicare Services Ltd.
330.85
5.60 (1.72%)
Supriya Lifescience Ltd.
900.65
22.80 (2.60%)
Gufic Biosciences Ltd.
425.50
5.65 (1.35%)
Aarti Drugs Ltd.
428.35
4.05 (0.95%)
SMS Pharmaceuticals Ltd.
413.75
10.80 (2.68%)
Indraprastha Medical Corporation Ltd.
363.65
7.10 (1.99%)
Unichem Laboratories Ltd.
538.45
14.20 (2.71%)
RPG Life Sciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in RPGLIFE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC